PLASMA-DERIVATIVE
PURPOSE:To provide a plasma-derivative containing a clinically safe and well controlled plasma component. CONSTITUTION:The plasma derivative contains a plasma component substantially containing one kind of antigen selected from among a) type A sugar chain antigen and H (O) type sugar chain antigen,...
Gespeichert in:
| Hauptverfasser: | , , |
|---|---|
| Format: | Patent |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | MATSUI HIROE MIZUOCHI TSUGIO CHITANI KOUICHI |
| description | PURPOSE:To provide a plasma-derivative containing a clinically safe and well controlled plasma component. CONSTITUTION:The plasma derivative contains a plasma component substantially containing one kind of antigen selected from among a) type A sugar chain antigen and H (O) type sugar chain antigen, b) type B sugar chain antigen and H (O) type sugar chain antigen, c) type A sugar chain antigen, B type sugar chain antigen, and H (O) type sugar chain antigen, and H (O) type, and d) H (O) type sugar chain antigen as an effective component. In addition, the plasma derivative also contains a plasma component from which the A type and B type sugar chain antigens are removed as another effective component. Therefore, this plasma derivative is useful for the transfusion, etc., of a plasma- derived component at the time of treating patients suffering from hemophilia, vW disease, etc. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_JPH06281650A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>JPH06281650A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_JPH06281650A3</originalsourceid><addsrcrecordid>eNrjZBAM8HEM9nXUdXEN8gxzDPEMc-VhYE1LzClO5YXS3AyKbq4hzh66qQX58anFBYnJqXmpJfFeAR4GZkYWhmamBo7GxKgBACzuHhA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>PLASMA-DERIVATIVE</title><source>esp@cenet</source><creator>MATSUI HIROE ; MIZUOCHI TSUGIO ; CHITANI KOUICHI</creator><creatorcontrib>MATSUI HIROE ; MIZUOCHI TSUGIO ; CHITANI KOUICHI</creatorcontrib><description>PURPOSE:To provide a plasma-derivative containing a clinically safe and well controlled plasma component. CONSTITUTION:The plasma derivative contains a plasma component substantially containing one kind of antigen selected from among a) type A sugar chain antigen and H (O) type sugar chain antigen, b) type B sugar chain antigen and H (O) type sugar chain antigen, c) type A sugar chain antigen, B type sugar chain antigen, and H (O) type sugar chain antigen, and H (O) type, and d) H (O) type sugar chain antigen as an effective component. In addition, the plasma derivative also contains a plasma component from which the A type and B type sugar chain antigens are removed as another effective component. Therefore, this plasma derivative is useful for the transfusion, etc., of a plasma- derived component at the time of treating patients suffering from hemophilia, vW disease, etc.</description><edition>5</edition><language>eng</language><subject>CHEMISTRY ; COMPOSITIONS BASED THEREON ; DERIVATIVES THEREOF ; HUMAN NECESSITIES ; HYGIENE ; INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES ; MEASURING ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC MACROMOLECULAR COMPOUNDS ; PHYSICS ; POLYSACCHARIDES ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS ; TESTING ; THEIR PREPARATION OR CHEMICAL WORKING-UP</subject><creationdate>1994</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=19941007&DB=EPODOC&CC=JP&NR=H06281650A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76290</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=19941007&DB=EPODOC&CC=JP&NR=H06281650A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>MATSUI HIROE</creatorcontrib><creatorcontrib>MIZUOCHI TSUGIO</creatorcontrib><creatorcontrib>CHITANI KOUICHI</creatorcontrib><title>PLASMA-DERIVATIVE</title><description>PURPOSE:To provide a plasma-derivative containing a clinically safe and well controlled plasma component. CONSTITUTION:The plasma derivative contains a plasma component substantially containing one kind of antigen selected from among a) type A sugar chain antigen and H (O) type sugar chain antigen, b) type B sugar chain antigen and H (O) type sugar chain antigen, c) type A sugar chain antigen, B type sugar chain antigen, and H (O) type sugar chain antigen, and H (O) type, and d) H (O) type sugar chain antigen as an effective component. In addition, the plasma derivative also contains a plasma component from which the A type and B type sugar chain antigens are removed as another effective component. Therefore, this plasma derivative is useful for the transfusion, etc., of a plasma- derived component at the time of treating patients suffering from hemophilia, vW disease, etc.</description><subject>CHEMISTRY</subject><subject>COMPOSITIONS BASED THEREON</subject><subject>DERIVATIVES THEREOF</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES</subject><subject>MEASURING</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC MACROMOLECULAR COMPOUNDS</subject><subject>PHYSICS</subject><subject>POLYSACCHARIDES</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><subject>TESTING</subject><subject>THEIR PREPARATION OR CHEMICAL WORKING-UP</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>1994</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZBAM8HEM9nXUdXEN8gxzDPEMc-VhYE1LzClO5YXS3AyKbq4hzh66qQX58anFBYnJqXmpJfFeAR4GZkYWhmamBo7GxKgBACzuHhA</recordid><startdate>19941007</startdate><enddate>19941007</enddate><creator>MATSUI HIROE</creator><creator>MIZUOCHI TSUGIO</creator><creator>CHITANI KOUICHI</creator><scope>EVB</scope></search><sort><creationdate>19941007</creationdate><title>PLASMA-DERIVATIVE</title><author>MATSUI HIROE ; MIZUOCHI TSUGIO ; CHITANI KOUICHI</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_JPH06281650A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>1994</creationdate><topic>CHEMISTRY</topic><topic>COMPOSITIONS BASED THEREON</topic><topic>DERIVATIVES THEREOF</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES</topic><topic>MEASURING</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC MACROMOLECULAR COMPOUNDS</topic><topic>PHYSICS</topic><topic>POLYSACCHARIDES</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><topic>TESTING</topic><topic>THEIR PREPARATION OR CHEMICAL WORKING-UP</topic><toplevel>online_resources</toplevel><creatorcontrib>MATSUI HIROE</creatorcontrib><creatorcontrib>MIZUOCHI TSUGIO</creatorcontrib><creatorcontrib>CHITANI KOUICHI</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>MATSUI HIROE</au><au>MIZUOCHI TSUGIO</au><au>CHITANI KOUICHI</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>PLASMA-DERIVATIVE</title><date>1994-10-07</date><risdate>1994</risdate><abstract>PURPOSE:To provide a plasma-derivative containing a clinically safe and well controlled plasma component. CONSTITUTION:The plasma derivative contains a plasma component substantially containing one kind of antigen selected from among a) type A sugar chain antigen and H (O) type sugar chain antigen, b) type B sugar chain antigen and H (O) type sugar chain antigen, c) type A sugar chain antigen, B type sugar chain antigen, and H (O) type sugar chain antigen, and H (O) type, and d) H (O) type sugar chain antigen as an effective component. In addition, the plasma derivative also contains a plasma component from which the A type and B type sugar chain antigens are removed as another effective component. Therefore, this plasma derivative is useful for the transfusion, etc., of a plasma- derived component at the time of treating patients suffering from hemophilia, vW disease, etc.</abstract><edition>5</edition><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng |
| recordid | cdi_epo_espacenet_JPH06281650A |
| source | esp@cenet |
| subjects | CHEMISTRY COMPOSITIONS BASED THEREON DERIVATIVES THEREOF HUMAN NECESSITIES HYGIENE INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES MEASURING MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC MACROMOLECULAR COMPOUNDS PHYSICS POLYSACCHARIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS TESTING THEIR PREPARATION OR CHEMICAL WORKING-UP |
| title | PLASMA-DERIVATIVE |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-01T13%3A45%3A40IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=MATSUI%20HIROE&rft.date=1994-10-07&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EJPH06281650A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |